Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Cholinesterases: Distribution and Function01:22

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adrenal hemorrhage: diagnostics, management, and treatment. Review and clinical update.

Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques·2025
Same author

Characteristics of Adrenal Hemorrhage: A Single Clinic's Experience.

Polski przeglad chirurgiczny·2024
Same author

Huge Hematoma as First Manifestation of Adrenocortical Carcinoma: A Case Report.

The American journal of case reports·2023
Same author

Cerebral Diseases in Liver Transplant Recipients: Systematic Review of Clinical Evidence.

Journal of clinical medicine·2022
Same author

Postoperative Analgesia after Open Liver Surgery: Systematic Review of Clinical Evidence.

Journal of clinical medicine·2021
Same author

Association between disease-related malnutrition and innate immunity gene expression in critically ill patients at intensive care unit admission.

Central-European journal of immunology·2021

Related Experiment Video

Updated: May 30, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

[Congenital pseudocholinesterase deficiency].

Remigiusz Gelo1, Anna Jurek-Gelo, Ryszard Wardaszko

  • 1II Klinika Anestezjologii i Intensywnej Terapii, Warszawski Uniwersytet Medyczny.

Anestezjologia Intensywna Terapia
|July 27, 2011
PubMed
Summary

Congenital pseudocholinesterase (pChe) deficiency can cause prolonged muscle relaxation after mivacurium use. Prompt measurement of pChe activity is crucial for diagnosing this rare genetic condition.

More Related Videos

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Related Experiment Videos

Last Updated: May 30, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess
07:35

Assessment of Open Probability of the Mitochondrial Permeability Transition Pore in the Setting of Coenzyme Q Excess

Published on: June 1, 2022

Quantification of Coenzyme A in Cells and Tissues
08:51

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Area of Science:

  • Anesthesiology
  • Pharmacogenetics
  • Neuromuscular blockade

Background:

  • Congenital pseudocholinesterase (pChe) deficiency is a rare genetic disorder.
  • It affects the metabolism of certain muscle relaxants, including mivacurium.
  • This deficiency can lead to unexpectedly prolonged neuromuscular blockade.

Observation:

  • Two male patients (26 and 7 years old) experienced prolonged neuromuscular block after receiving mivacurium during surgery.
  • Neuromuscular transmission recovery took 7 and 4 hours, respectively, with no response to standard reversal agents.
  • Postoperative assays confirmed severe pChe deficiency in both patients.

Findings:

  • Severe pChe deficiency was identified in both patients, with enzyme activity significantly below normal ranges.
  • Family screening confirmed the genetic basis of the deficiency in both cases.
  • Mivacurium hydrolysis was impaired due to low pseudocholinesterase levels.

Implications:

  • Consider pChe deficiency in cases of prolonged muscle relaxation post-mivacurium.
  • Measuring pChe activity is essential for diagnosis.
  • Mandatory family screening is recommended upon confirmation of pChe deficiency.